Wealth Enhancement Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253K Sell
903
-265
-23% -$76.3K ﹤0.01% 2940
2025
Q4
$380K Buy
1,168
+95
+9% +$29.6K ﹤0.01% 2708
2025
Q3
$318K Buy
1,073
+128
+14% +$34.8K ﹤0.01% 2737
2025
Q2
$238K Buy
+945
New +$223K ﹤0.01% 2845
2025
Q1
Sell
-895
Closed -$294K 3000
2024
Q4
$294K Buy
895
+38
+4% +$12.9K ﹤0.01% 2398
2024
Q3
$287K Sell
857
-90
-10% -$28.6K ﹤0.01% 2210
2024
Q2
$259K Buy
947
+82
+9% +$23.9K ﹤0.01% 2085
2024
Q1
$299K Buy
865
+72
+9% +$23.7K ﹤0.01% 1921
2023
Q4
$256K Sell
793
-321
-29% -$101K ﹤0.01% 1929
2023
Q3
$399K Buy
+1,114
New +$430K ﹤0.01% 1568
2018
Q1
Sell
-1,324
Closed -$329K 144
2017
Q4
$329K Buy
+1,324
New +$321K 0.02% 135
2016
Q2
Sell
-8,161
Closed -$1.11M 115
2016
Q1
$1.11M Buy
8,161
+1,319
+19% +$173K 0.23% 92
2015
Q4
$949K Buy
+6,842
New +$948K 0.24% 92

Other funds holding BIO